CANTON BIOLOGICS

Live / Registered — Registered — Section 8 accepted (as of 17 Nov 2026)

What this means for you

Registered since 15 Sept 2020. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 15 Sept 2030: the §8 & §9 renewal).

Record

Serial number
88513445
Registration number
6154612
Mark type
Word mark
Kind
Trademark and service mark
Register
Principal
Basis
Use in commerce (§1(a))
Filed
14 Jul 2019
Published for opposition
31 Dec 2019
Registered
15 Sept 2020
Next maintenance filing
§8 & §9 renewal, due by 15 Sept 2030 (grace period to 15 Mar 2031)
Examining attorney
Chioma Oputa
Attorney of record
Yue (Robert) Xu

Goods and services

  • Class 001 — Chemicals: [ Proteins for use in the manufacture of food supplements; proteins for the food industry; ] protein for use in the manufacture of cosmetics; protein in raw material form for scientific and medical research; protein for industrial use; [ animal albumen for use in the manufacture of skin care product; animal albumen as a raw material for industrial use; diagnostic preparations other than for medical or veterinary purposes; ] biological preparations for use in industry and science; biological preparation for use in cell cultures other than for medical or veterinary use; cultures of microorganisms, other than for medical and veterinary use; [ chemical preparations for analyses in laboratories, other than for medical or veterinary purposes; biological tissue cultures, other than for medical or veterinary purposes; biochemical catalysts; stem cells, other than for medical or veterinary purposes ]
  • Class 005 — Pharmaceuticals: Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-inflammatories, anti-virals, anti-infectives, immunosuppressants and pharmaceutical antibodies; pharmaceuticals, namely, preparations for antibody and antibody-derivative development; pharmaceuticals, namely, antibodies and proteins for the treatment of oncological and autoimmune diseases and disorders; cytokine preparations and antibodies in the nature of pharmaceutical preparations for the treatment of oncological and autoimmune diseases and disorders; pharmaceutical preparations, namely, immuno- therapeutics and cytokines for the treatment of oncological and autoimmune diseases and disorders; diagnostic preparations for medical purposes for detecting the presence of malignant, inflammatory and autoimmune disorders and conditions and tissue trauma in humans; medicines for the treatment of gastrointestinal diseases, for human purposes; pharmaceutical products for the prevention and treatment of cancer, for human purposes; tumor suppressing agents, for human purpose; [ pharmaceutical preparations for use in chemotherapy; ] pharmaceutical preparations for the treatment of musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; pharmaceutical preparations for peripheral nervous system; vaccines; diagnostic preparations for medical purposes; chemical preparations for medical purposes, namely, for treating cancer; nutritional supplements; biocides; surgical glues ]
  • Class 042 — Scientific and technological services: Biological research; medical and scientific research, namely, conducting clinical trials for others; research and development services in the field of antibodies; biotechnology research; testing of pharmaceuticals; analysis of the mode of action of chemical combinations on animals; bacteriological research; scientific laboratory services; scientific research; biomedical research services

Owner

Prosecution history

  • 17 Nov 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
  • 17 Nov 2026 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
  • 14 Nov 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
  • 14 Sept 2026 — TEAS SECTION 8 RECEIVED
  • 15 Sept 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
  • 03 May 2023 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
  • 15 Sept 2020 — REGISTERED-PRINCIPAL REGISTER
  • 14 Aug 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
  • 13 Aug 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
  • 24 Jul 2020 — STATEMENT OF USE PROCESSING COMPLETE
  • 05 Jul 2020 — USE AMENDMENT FILED
  • 24 Jul 2020 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
  • 05 Jul 2020 — TEAS STATEMENT OF USE RECEIVED
  • 25 Feb 2020 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
  • 31 Dec 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

View this trademark record on Rightsy